| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0005 |